WEE1
TYR version of PSPA with Y as phospho-acceptor
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O15357 | Y190 | Sugiyama | INPPL1 SHIP2 | AAESAPNGLSTVSHDYLKGsyGLDLEAVRGGASHLPHLTRT |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43615 | Y201 | Sugiyama | TIMM44 MIMT44 TIM44 | QGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKFKEE |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05787 | Y282 | Sugiyama | KRT8 CYK8 | EVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRR |
| P06493 | T14 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | _______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKK |
| P06493 | Y15 | SIGNOR|ELM|iPTMNet|EPSD|PSP | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKI |
| P06730 | Y197 | Sugiyama | EIF4E EIF4EL1 EIF4F | THIGRVYKERLGLPPKIVIGyQsHADTAtKsGsttKNRFVV |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y257 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | TDKVVIGMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLA |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07686 | Y310 | Sugiyama | HEXB HCC7 | DTPGHTLSWGKGQKDLLtPCySRQNKLDSFGPINPTLNTTY |
| P07711 | Y330 | Sugiyama | CTSL CTSL1 | GyVKMAKDRRNHCGIAsAAsyPtV_________________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y38 | EPSD|PSP | HSP90AA1 HSP90A HSPC1 HSPCA | ETFAFQAEIAQLMSLIINtFySNKEIFLRELIsNssDALDK |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08758 | Y91 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | SELTGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLt |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09960 | Y233 | Sugiyama | LTA4H LTA4 | RQIGPRTLVWSEKEQVEKSAyEFsETEsMLKIAEDLGGPYV |
| P0C7P4 | Y100 | Sugiyama | UQCRFS1P1 UQCRFSL1 | NVPASVCYSHTDIKVPDFSEyRRLEVLDSTKSSRESTEARK |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11308 | Y183 | SIGNOR|PSP | ERG | IDGKELCKMTKDDFQRLtPSyNADILLSHLHYLRETPLPHL |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13010 | Y316 | Sugiyama | XRCC5 G22P2 | CLNDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSE |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y677 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDM |
| P14625 | Y678 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDML |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15328 | Y82 | Sugiyama | FOLR1 FOLR | KNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRHFIQ |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18621 | Y4 | Sugiyama | RPL17 | _________________MVRysLDPENPtKsCKSRGSNLRV |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P21333 | Y1632 | Sugiyama | FLNA FLN FLN1 | VTGRYTILIKYGGDEIPFsPyRVRAVPTGDASKCTVTVSIG |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | Y331 | Sugiyama | HNRNPA2B1 HNRPA2B1 | SNYGPMKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRs |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P22626 | Y347 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MGGPyGGGNyGPGGsGGsGGyGGRsRy______________ |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y219 | Sugiyama | ACAT1 ACAT MAT | NTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVt |
| P24941 | T14 | EPSD|Sugiyama | CDK2 CDKN2 | _______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKK |
| P24941 | Y15 | SIGNOR|iPTMNet|EPSD|PSP | CDK2 CDKN2 | ______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKKI |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P29401 | S308 | Sugiyama | TKT | PPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQALAKL |
| P30041 | Y89 | Sugiyama | PRDX6 AOP2 KIAA0106 | IALSIDSVEDHLAWSKDINAyNCEEPtEKLPFPIIDDRNRE |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30291 | S270 | Sugiyama | WEE1 | QCRRRKRTyWNDSCGEDMEAsDyELEDETRPAKRITITESN |
| P30291 | S293 | Sugiyama | WEE1 | ELEDETRPAKRITITESNMKsRytTEFHELEKIGSGEFGsV |
| P30291 | S444 | Sugiyama | WEE1 | HMDIKPSNIFISRTSIPNAAsEEGDEDDWASNKVMFKIGDL |
| P30291 | T173 | iPTMNet|EPSD | WEE1 | GCGARRAGEGRRsPRPDHPGtPPHKTFRKLRLFDTPHtPKS |
| P30291 | T296 | Sugiyama | WEE1 | DETRPAKRITITESNMKsRytTEFHELEKIGSGEFGsVFKC |
| P30291 | T615 | Sugiyama | WEE1 | QKELKKAQMAKAAAEERALFtDRMATRSTTQSNRTSRLIGK |
| P30291 | Y258 | Sugiyama | WEE1 | FtPDsLLLHSSGQCRRRKRTyWNDSCGEDMEAsDyELEDET |
| P30291 | Y272 | Sugiyama | WEE1 | RRRKRTyWNDSCGEDMEAsDyELEDETRPAKRITITESNMK |
| P30291 | Y295 | Sugiyama | WEE1 | EDETRPAKRITITESNMKsRytTEFHELEKIGSGEFGsVFK |
| P30291 | Y325 | Sugiyama | WEE1 | IGSGEFGsVFKCVKRLDGCIyAIKRSKKPLAGSVDEQNALR |
| P31327 | T166 | Sugiyama | CPS1 | TKsLGQWLQEEKVPAIyGVDtRMLTKIIRDKGTMLGKIEFE |
| P31327 | Y162 | Sugiyama | CPS1 | HWLATKsLGQWLQEEKVPAIyGVDtRMLTKIIRDKGTMLGK |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P47985 | Y91 | Sugiyama | UQCRFS1 | NVPASVCYSHTDIKVPDFSEyRRLEVLDstKSSRESSEARK |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | S2032 | Sugiyama | FASN FAS | ELDYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEG |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P50395 | Y203 | Sugiyama | GDI2 RABGDIB | DFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsP |
| P50502 | Y185 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | NAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P51858 | S165 | Sugiyama | HDGF HMG1L2 | AKEKNEKGALKRRAGDLLEDsPKRPKEAENPEGEEKEAAtL |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52789 | S415 | Sugiyama | HK2 | QRIKENKGEERLRstIGVDGsVyKKHPHFAKRLHKTVRRLV |
| P52789 | Y417 | Sugiyama | HK2 | IKENKGEERLRstIGVDGsVyKKHPHFAKRLHKTVRRLVPG |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60228 | Y445 | Sugiyama | EIF3E EIF3S6 INT6 | KLNQNSRSEAPNWAtQDsGFy____________________ |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P61081 | T176 | Sugiyama | UBE2M UBC12 | NRRLFEQNVQRSMRGGyIGstyFERCLK_____________ |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61247 | Y31 | Sugiyama | RPS3A FTE1 MFTL | KGGKKGAKKKVVDPFSKKDWyDVKAPAMFNIRNIGKTLVTR |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62249 | Y115 | Sugiyama | RPS16 | YYQKYVDEASKKEIKDILIQyDRtLLVADPRRCESKKFGGP |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | Y72 | Sugiyama | RPS14 PRO2640 | TICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGITA |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | Y158 | Sugiyama | YBX1 NSEP1 YB1 | YAADRNHYRRYPRRRGPPRNyQQNyQNsEsGEKNEGsEsAP |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| Q00526 | T14 | Sugiyama | CDK3 CDKN3 | _______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKK |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q02878 | Y116 | Sugiyama | RPL6 TXREB1 | VGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQH |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07866 | Y474 | Sugiyama | KLC1 KLC KNS2 | KACKVDsPtVTTtLKNLGALyRRQGKFEAAETLEEAAMRSR |
| Q08211 | Y132 | Sugiyama | DHX9 DDX9 LKP NDH2 | PLPPHLALKAENNsEVGAsGyGVPGPTWDRGANLKDYYSRK |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14980 | Y1836 | Sugiyama | NUMA1 NMP22 NUMA | NITMTKKLDVEEPDsANssFystRsAPAsQAsLRAtsstQs |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q16658 | Y493 | Sugiyama | FSCN1 FAN1 HSN SNL | DHAGVLKASAEtVDPAsLWEy____________________ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q1KMD3 | Y215 | Sugiyama | HNRNPUL2 HNRPUL2 | GERRGVKRQRDEKDEHGRAyyEFREEAYHsRsKsPLPPEEE |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6PKG0 | Y777 | Sugiyama | LARP1 KIAA0731 LARP | APEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDSSQT |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8NFI4 | Y185 | Sugiyama | ST13P5 FAM10A5 | NAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| Q93052 | Y301 | Sugiyama | LPP | LQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQG |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q96EA4 | Y223 | Sugiyama | SPDL1 CCDC99 | RQVDRLKEEKEEREKEAVSYyNALEKARVANQDLQVQLDQA |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99798 | Y71 | Sugiyama | ACO2 | NINIVRKRLNRPLTLSEKIVyGHLDDPAsQEIERGKSYLRL |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q9BQE3 | Y449 | Sugiyama | TUBA1C TUBA6 | EKDyEEVGADsADGEDEGEEy____________________ |
| Q9BS26 | Y395 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | AQDVASSPPESSFQKLAPsEyRytLLRDRDEL_________ |
| Q9BS26 | Y397 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | DVASSPPESSFQKLAPsEyRytLLRDRDEL___________ |
| Q9BUJ2 | Y111 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | GYSGPDGHYAMDNITRQNQFyDtQVIKQENESGyERRPLEM |
| Q9BUJ2 | Y510 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | RLIQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIV |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9HB71 | Y78 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | EKPAAVVAPITTGytVKISNyGWDQSDKFVKIyITLTGVHQ |
| Q9NSK0 | Y474 | Sugiyama | KLC4 KNSL8 | KACKVssPTVNTTLRNLGALyRRQGKLEAAETLEECALRSR |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.275147e-11 | 10.082 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.361955e-06 | 5.866 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.477042e-05 | 4.831 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.231121e-05 | 4.910 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.209229e-05 | 4.917 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.355647e-06 | 5.029 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.517683e-06 | 5.186 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.569324e-05 | 4.804 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.209229e-05 | 4.917 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.123661e-06 | 5.090 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.152518e-05 | 4.938 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.521140e-05 | 4.818 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.008556e-05 | 4.697 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.334514e-05 | 4.632 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.026391e-05 | 4.395 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.829195e-05 | 4.234 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.670473e-05 | 4.246 | 1 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.312727e-05 | 4.200 | 1 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.703659e-05 | 4.060 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.031505e-04 | 3.987 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.032734e-04 | 3.986 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.032734e-04 | 3.986 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.152891e-04 | 3.938 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.119619e-04 | 3.951 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.417167e-04 | 3.849 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.632865e-04 | 3.787 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.832531e-04 | 3.737 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.897671e-04 | 3.722 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.006742e-04 | 3.698 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.832823e-04 | 3.548 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.907773e-04 | 3.536 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.507533e-04 | 3.455 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.331711e-04 | 3.477 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.598707e-04 | 3.444 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.861822e-04 | 3.413 | 1 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.938463e-04 | 3.405 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.444656e-04 | 3.352 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.682005e-04 | 3.330 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.342093e-04 | 3.272 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.821860e-04 | 3.235 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.182448e-04 | 3.209 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.365195e-04 | 3.196 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.824213e-04 | 3.166 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.605130e-04 | 3.180 | 1 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.741013e-04 | 3.111 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.056870e-04 | 3.094 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.094355e-04 | 3.092 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.297585e-04 | 3.081 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.265067e-04 | 3.033 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.018751e-03 | 2.992 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.211988e-03 | 2.917 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.261246e-03 | 2.899 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.261246e-03 | 2.899 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.346687e-03 | 2.871 | 1 | 1 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.431132e-03 | 2.844 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.503718e-03 | 2.823 | 1 | 1 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.589230e-03 | 2.799 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.487439e-03 | 2.828 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.605418e-03 | 2.794 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.747009e-03 | 2.758 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.802435e-03 | 2.744 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.804033e-03 | 2.744 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.804033e-03 | 2.744 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.142638e-03 | 2.669 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.280424e-03 | 2.642 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.142638e-03 | 2.669 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.142638e-03 | 2.669 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.032679e-03 | 2.692 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.289643e-03 | 2.640 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.142638e-03 | 2.669 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.439061e-03 | 2.613 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.439061e-03 | 2.613 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.830170e-03 | 2.548 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.792657e-03 | 2.554 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.816362e-03 | 2.550 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.974063e-03 | 2.527 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.974063e-03 | 2.527 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.974063e-03 | 2.527 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.164416e-03 | 2.500 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.164416e-03 | 2.500 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.133001e-03 | 2.504 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.432018e-03 | 2.464 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.414734e-03 | 2.467 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.164416e-03 | 2.500 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.133001e-03 | 2.504 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.155918e-03 | 2.501 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.454994e-03 | 2.462 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.454994e-03 | 2.462 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.454994e-03 | 2.462 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.549593e-03 | 2.450 | 1 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.566303e-03 | 2.448 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.796517e-03 | 2.421 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.929656e-03 | 2.406 | 1 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.978211e-03 | 2.400 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.978211e-03 | 2.400 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.941719e-03 | 2.306 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 4.413145e-03 | 2.355 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.723093e-03 | 2.326 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.364728e-03 | 2.270 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.808866e-03 | 2.236 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.863729e-03 | 2.232 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 5.863729e-03 | 2.232 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.863729e-03 | 2.232 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.900319e-03 | 2.229 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.900319e-03 | 2.229 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.900319e-03 | 2.229 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.573806e-03 | 2.182 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.108765e-03 | 2.214 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.931822e-03 | 2.159 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.012465e-03 | 2.221 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.414986e-03 | 2.193 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.270706e-03 | 2.138 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.653323e-03 | 2.116 | 1 | 0 |
| Integrin signaling | R-HSA-354192 | 7.801935e-03 | 2.108 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.801935e-03 | 2.108 | 1 | 1 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.801935e-03 | 2.108 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.081098e-03 | 2.093 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.081098e-03 | 2.093 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.209285e-03 | 2.086 | 0 | 0 |
| Drug resistance of ALK mutants | R-HSA-9700649 | 1.019454e-02 | 1.992 | 0 | 0 |
| ASP-3026-resistant ALK mutants | R-HSA-9717264 | 1.019454e-02 | 1.992 | 0 | 0 |
| crizotinib-resistant ALK mutants | R-HSA-9717326 | 1.019454e-02 | 1.992 | 0 | 0 |
| NVP-TAE684-resistant ALK mutants | R-HSA-9717301 | 1.019454e-02 | 1.992 | 0 | 0 |
| alectinib-resistant ALK mutants | R-HSA-9717316 | 1.019454e-02 | 1.992 | 0 | 0 |
| brigatinib-resistant ALK mutants | R-HSA-9717319 | 1.019454e-02 | 1.992 | 0 | 0 |
| lorlatinib-resistant ALK mutants | R-HSA-9717329 | 1.019454e-02 | 1.992 | 0 | 0 |
| ceritinib-resistant ALK mutants | R-HSA-9717323 | 1.019454e-02 | 1.992 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.931622e-03 | 2.049 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.236780e-03 | 2.034 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.236780e-03 | 2.034 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.536623e-03 | 2.069 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.015222e-02 | 1.993 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.369808e-03 | 2.028 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.931622e-03 | 2.049 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.015222e-02 | 1.993 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.773603e-03 | 2.057 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.102321e-02 | 1.958 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.135530e-02 | 1.945 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.136528e-02 | 1.944 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.146506e-02 | 1.941 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.199870e-02 | 1.921 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.199870e-02 | 1.921 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.199870e-02 | 1.921 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.287129e-02 | 1.890 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.345552e-02 | 1.871 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.325832e-02 | 1.878 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.345552e-02 | 1.871 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.345552e-02 | 1.871 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.345552e-02 | 1.871 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.648838e-02 | 1.783 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.345552e-02 | 1.871 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.345552e-02 | 1.871 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.561574e-02 | 1.806 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.333021e-02 | 1.875 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.437186e-02 | 1.842 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.325832e-02 | 1.878 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.325832e-02 | 1.878 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.658570e-02 | 1.780 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.658570e-02 | 1.780 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.736435e-02 | 1.760 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.764626e-02 | 1.753 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.764626e-02 | 1.753 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.764626e-02 | 1.753 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.765894e-02 | 1.753 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.825099e-02 | 1.739 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.825585e-02 | 1.739 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.825585e-02 | 1.739 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.825585e-02 | 1.739 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.825585e-02 | 1.739 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.825585e-02 | 1.739 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.854067e-02 | 1.732 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.854067e-02 | 1.732 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.028577e-02 | 1.693 | 0 | 0 |
| Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) | R-HSA-5619110 | 2.028577e-02 | 1.693 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.179846e-02 | 1.662 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.944648e-02 | 1.711 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.433750e-02 | 1.614 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.230866e-02 | 1.652 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.037641e-02 | 1.691 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.433750e-02 | 1.614 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.538813e-02 | 1.595 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.146727e-02 | 1.668 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.383469e-02 | 1.623 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.442723e-02 | 1.612 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.527052e-02 | 1.597 | 1 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.538813e-02 | 1.595 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.944648e-02 | 1.711 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.179846e-02 | 1.662 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.366786e-02 | 1.626 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.240877e-02 | 1.650 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.999395e-02 | 1.699 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.014196e-02 | 1.696 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.646286e-02 | 1.577 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.729564e-02 | 1.564 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.756167e-02 | 1.560 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.756167e-02 | 1.560 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.759537e-02 | 1.559 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.759537e-02 | 1.559 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.814860e-02 | 1.551 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.868453e-02 | 1.542 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.970206e-02 | 1.527 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.983139e-02 | 1.525 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.027473e-02 | 1.519 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.027473e-02 | 1.519 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.137406e-02 | 1.503 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.176481e-02 | 1.498 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.274469e-02 | 1.485 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.292349e-02 | 1.482 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.341544e-02 | 1.476 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.341544e-02 | 1.476 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.016246e-02 | 1.396 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.016246e-02 | 1.396 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.016246e-02 | 1.396 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.016246e-02 | 1.396 | 0 | 0 |
| Defective ADA disrupts (deoxy)adenosine deamination | R-HSA-9734735 | 4.016246e-02 | 1.396 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.994998e-02 | 1.301 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.994998e-02 | 1.301 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.994998e-02 | 1.301 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.994998e-02 | 1.301 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.994998e-02 | 1.301 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.616488e-02 | 1.442 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.844797e-02 | 1.415 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.317356e-02 | 1.365 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.561346e-02 | 1.341 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.721326e-02 | 1.429 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.721326e-02 | 1.429 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.122262e-02 | 1.385 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.844797e-02 | 1.415 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.721326e-02 | 1.429 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.994998e-02 | 1.301 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 4.810305e-02 | 1.318 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.810305e-02 | 1.318 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.544078e-02 | 1.343 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.488151e-02 | 1.457 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.765573e-02 | 1.424 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.393671e-02 | 1.469 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.616488e-02 | 1.442 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.561346e-02 | 1.341 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.488151e-02 | 1.457 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.561346e-02 | 1.341 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.616488e-02 | 1.442 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.154681e-02 | 1.381 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.047485e-02 | 1.297 | 1 | 1 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.844797e-02 | 1.415 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.577748e-02 | 1.446 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.530761e-02 | 1.344 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 4.869037e-02 | 1.313 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 4.869037e-02 | 1.313 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.888471e-02 | 1.311 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.836736e-02 | 1.315 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.643593e-02 | 1.438 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.643593e-02 | 1.438 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.401171e-02 | 1.356 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.211639e-02 | 1.376 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.877998e-02 | 1.411 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.064108e-02 | 1.295 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.138431e-02 | 1.289 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.138431e-02 | 1.289 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.138431e-02 | 1.289 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.242581e-02 | 1.280 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.322632e-02 | 1.274 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.322632e-02 | 1.274 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.449055e-02 | 1.264 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.453646e-02 | 1.263 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.585756e-02 | 1.253 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.585756e-02 | 1.253 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.853360e-02 | 1.233 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.853360e-02 | 1.233 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.930222e-02 | 1.227 | 1 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.931471e-02 | 1.227 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.963829e-02 | 1.224 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.963829e-02 | 1.224 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.963829e-02 | 1.224 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.963829e-02 | 1.224 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.963829e-02 | 1.224 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.963829e-02 | 1.224 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.922840e-02 | 1.160 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.922840e-02 | 1.160 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.872129e-02 | 1.104 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.872129e-02 | 1.104 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.872129e-02 | 1.104 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.872129e-02 | 1.104 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.872129e-02 | 1.104 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.872129e-02 | 1.104 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 8.811794e-02 | 1.055 | 1 | 1 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 8.811794e-02 | 1.055 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.741933e-02 | 1.011 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 9.741933e-02 | 1.011 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 9.741933e-02 | 1.011 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 9.741933e-02 | 1.011 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.741933e-02 | 1.011 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.066264e-01 | 0.972 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.066264e-01 | 0.972 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.066264e-01 | 0.972 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.157401e-01 | 0.937 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.157401e-01 | 0.937 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.157401e-01 | 0.937 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.157401e-01 | 0.937 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.546623e-02 | 1.122 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.240198e-02 | 1.084 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.824899e-02 | 1.008 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.620439e-02 | 1.017 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.060438e-02 | 1.043 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.065411e-01 | 0.972 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.065411e-01 | 0.972 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.065411e-01 | 0.972 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.922840e-02 | 1.160 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.000782e-01 | 1.000 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.141780e-02 | 1.089 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.131130e-01 | 0.946 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 8.811794e-02 | 1.055 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.065411e-01 | 0.972 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.966257e-02 | 1.157 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.872129e-02 | 1.104 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.065411e-01 | 0.972 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.954062e-02 | 1.158 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 1.066264e-01 | 0.972 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.157401e-01 | 0.937 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.966257e-02 | 1.157 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.966257e-02 | 1.157 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.060438e-02 | 1.043 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.060438e-02 | 1.043 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.098138e-01 | 0.959 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.507298e-02 | 1.187 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.114365e-01 | 0.953 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.000782e-01 | 1.000 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.000782e-01 | 1.000 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.546623e-02 | 1.122 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.141780e-02 | 1.089 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.944779e-02 | 1.100 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.922840e-02 | 1.160 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 7.872129e-02 | 1.104 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 8.811794e-02 | 1.055 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.157401e-01 | 0.937 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.254539e-02 | 1.139 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.254539e-02 | 1.139 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 7.546623e-02 | 1.122 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.546623e-02 | 1.122 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.157228e-02 | 1.038 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.087315e-01 | 0.964 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.872129e-02 | 1.104 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 9.741933e-02 | 1.011 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.401541e-02 | 1.194 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.681888e-02 | 1.175 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.681888e-02 | 1.175 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.966257e-02 | 1.157 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.060438e-02 | 1.043 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.060438e-02 | 1.043 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.824899e-02 | 1.008 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.444644e-02 | 1.073 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.966257e-02 | 1.157 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.444644e-02 | 1.073 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.750897e-02 | 1.058 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.750897e-02 | 1.058 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.824899e-02 | 1.008 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.750181e-02 | 1.058 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.141780e-02 | 1.089 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.688998e-02 | 1.014 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.032956e-01 | 0.986 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.539701e-02 | 1.020 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.032956e-01 | 0.986 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.157401e-01 | 0.937 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.444644e-02 | 1.073 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.750897e-02 | 1.058 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.032956e-01 | 0.986 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.049106e-02 | 1.094 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.231600e-01 | 0.910 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.032956e-01 | 0.986 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.032956e-01 | 0.986 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.556174e-02 | 1.183 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.113139e-02 | 1.091 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.049224e-01 | 0.979 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.231600e-01 | 0.910 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.240198e-02 | 1.084 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.017820e-02 | 1.045 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.174163e-01 | 0.930 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.154999e-01 | 0.937 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.766021e-02 | 1.110 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.141780e-02 | 1.089 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.231600e-01 | 0.910 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.032956e-01 | 0.986 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.131783e-02 | 1.147 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.539701e-02 | 1.020 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.254539e-02 | 1.139 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.131130e-01 | 0.946 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.488060e-02 | 1.126 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.141780e-02 | 1.089 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.298894e-02 | 1.081 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.240950e-01 | 0.906 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.247614e-01 | 0.904 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.247614e-01 | 0.904 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.247614e-01 | 0.904 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.247614e-01 | 0.904 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.247614e-01 | 0.904 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.247614e-01 | 0.904 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.257464e-01 | 0.901 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.265560e-01 | 0.898 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.265560e-01 | 0.898 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.286229e-01 | 0.891 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.299743e-01 | 0.886 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.312394e-01 | 0.882 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.323119e-01 | 0.878 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.335591e-01 | 0.874 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.336913e-01 | 0.874 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.336913e-01 | 0.874 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.359266e-01 | 0.867 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.359266e-01 | 0.867 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.368741e-01 | 0.864 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.425305e-01 | 0.846 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.425305e-01 | 0.846 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.425305e-01 | 0.846 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.425305e-01 | 0.846 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.435253e-01 | 0.843 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.438532e-01 | 0.842 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.451368e-01 | 0.838 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.471208e-01 | 0.832 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.512801e-01 | 0.820 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.512801e-01 | 0.820 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.512801e-01 | 0.820 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.512801e-01 | 0.820 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.512801e-01 | 0.820 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.512801e-01 | 0.820 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.512801e-01 | 0.820 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.512801e-01 | 0.820 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 1.544574e-01 | 0.811 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.580254e-01 | 0.801 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.580254e-01 | 0.801 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.580254e-01 | 0.801 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.580254e-01 | 0.801 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.599410e-01 | 0.796 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 1.599410e-01 | 0.796 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 1.599410e-01 | 0.796 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.599410e-01 | 0.796 | 1 | 1 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.599410e-01 | 0.796 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.616089e-01 | 0.792 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.616089e-01 | 0.792 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 1.652072e-01 | 0.782 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.652072e-01 | 0.782 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.667956e-01 | 0.778 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.685140e-01 | 0.773 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.685140e-01 | 0.773 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.685140e-01 | 0.773 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.685140e-01 | 0.773 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 1.685140e-01 | 0.773 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.685140e-01 | 0.773 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.688196e-01 | 0.773 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.721535e-01 | 0.764 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.724455e-01 | 0.763 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.724455e-01 | 0.763 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.724455e-01 | 0.763 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.724455e-01 | 0.763 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.770001e-01 | 0.752 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.770001e-01 | 0.752 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.770001e-01 | 0.752 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.770001e-01 | 0.752 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.770001e-01 | 0.752 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.801775e-01 | 0.744 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.854000e-01 | 0.732 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 1.854000e-01 | 0.732 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.883251e-01 | 0.725 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.883251e-01 | 0.725 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.907548e-01 | 0.720 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.907548e-01 | 0.720 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.937148e-01 | 0.713 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.937148e-01 | 0.713 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.937148e-01 | 0.713 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.944484e-01 | 0.711 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.947362e-01 | 0.711 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.981511e-01 | 0.703 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.981511e-01 | 0.703 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.018625e-01 | 0.695 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.019452e-01 | 0.695 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.019452e-01 | 0.695 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.055820e-01 | 0.687 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.100920e-01 | 0.678 | 1 | 1 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.100920e-01 | 0.678 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.100920e-01 | 0.678 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.130429e-01 | 0.672 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.130832e-01 | 0.671 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.155779e-01 | 0.666 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.177188e-01 | 0.662 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.181562e-01 | 0.661 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.181562e-01 | 0.661 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.181562e-01 | 0.661 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.181562e-01 | 0.661 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.181562e-01 | 0.661 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.205297e-01 | 0.657 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.205297e-01 | 0.657 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.206328e-01 | 0.656 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.210594e-01 | 0.655 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.261386e-01 | 0.646 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.264105e-01 | 0.645 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.280383e-01 | 0.642 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.285095e-01 | 0.641 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 2.317867e-01 | 0.635 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.325662e-01 | 0.633 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.340400e-01 | 0.631 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.340400e-01 | 0.631 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.355648e-01 | 0.628 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.355648e-01 | 0.628 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.393335e-01 | 0.621 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.398946e-01 | 0.620 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.418611e-01 | 0.616 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.418611e-01 | 0.616 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.418611e-01 | 0.616 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 2.418611e-01 | 0.616 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.431052e-01 | 0.614 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.468796e-01 | 0.608 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.468796e-01 | 0.608 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.468796e-01 | 0.608 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.496029e-01 | 0.603 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.504783e-01 | 0.601 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.506561e-01 | 0.601 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.506561e-01 | 0.601 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.506561e-01 | 0.601 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.535114e-01 | 0.596 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.535114e-01 | 0.596 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.544344e-01 | 0.594 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.562486e-01 | 0.591 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.572661e-01 | 0.590 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.572661e-01 | 0.590 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 2.572661e-01 | 0.590 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 2.572661e-01 | 0.590 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.572661e-01 | 0.590 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.648516e-01 | 0.577 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.648516e-01 | 0.577 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.648516e-01 | 0.577 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.657753e-01 | 0.575 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.704531e-01 | 0.568 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.723600e-01 | 0.565 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.723600e-01 | 0.565 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.723600e-01 | 0.565 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.727535e-01 | 0.564 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.771169e-01 | 0.557 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.774014e-01 | 0.557 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.808958e-01 | 0.551 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.846733e-01 | 0.546 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.871489e-01 | 0.542 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.871489e-01 | 0.542 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.871489e-01 | 0.542 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 2.933248e-01 | 0.533 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.944309e-01 | 0.531 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.944309e-01 | 0.531 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.944309e-01 | 0.531 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.944309e-01 | 0.531 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.944309e-01 | 0.531 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.944309e-01 | 0.531 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.944309e-01 | 0.531 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.997615e-01 | 0.523 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.997615e-01 | 0.523 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.016390e-01 | 0.521 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.016390e-01 | 0.521 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.016390e-01 | 0.521 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.035264e-01 | 0.518 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.035264e-01 | 0.518 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.060630e-01 | 0.514 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.087739e-01 | 0.510 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.087739e-01 | 0.510 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.087739e-01 | 0.510 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.087739e-01 | 0.510 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.090471e-01 | 0.510 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.116378e-01 | 0.506 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.116678e-01 | 0.506 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.144265e-01 | 0.502 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.147990e-01 | 0.502 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.147990e-01 | 0.502 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.158363e-01 | 0.501 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.158363e-01 | 0.501 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.185480e-01 | 0.497 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.228271e-01 | 0.491 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.297468e-01 | 0.482 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.297468e-01 | 0.482 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.297468e-01 | 0.482 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 3.297468e-01 | 0.482 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.365962e-01 | 0.473 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.365962e-01 | 0.473 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 3.365962e-01 | 0.473 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.433760e-01 | 0.464 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.433760e-01 | 0.464 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.483461e-01 | 0.458 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.500870e-01 | 0.456 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.562133e-01 | 0.448 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.562533e-01 | 0.448 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.567298e-01 | 0.448 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.567298e-01 | 0.448 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.567298e-01 | 0.448 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.630879e-01 | 0.440 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.630879e-01 | 0.440 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.633051e-01 | 0.440 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.633051e-01 | 0.440 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.633051e-01 | 0.440 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 3.698136e-01 | 0.432 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.698136e-01 | 0.432 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.741140e-01 | 0.427 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.762560e-01 | 0.425 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.784553e-01 | 0.422 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.813374e-01 | 0.419 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.826329e-01 | 0.417 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.826329e-01 | 0.417 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.826329e-01 | 0.417 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.826329e-01 | 0.417 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.826329e-01 | 0.417 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.826329e-01 | 0.417 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.889450e-01 | 0.410 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.889450e-01 | 0.410 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.950066e-01 | 0.403 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.951930e-01 | 0.403 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.951930e-01 | 0.403 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.951930e-01 | 0.403 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.951930e-01 | 0.403 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.977547e-01 | 0.400 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.029413e-01 | 0.395 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.029413e-01 | 0.395 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.074990e-01 | 0.390 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.128986e-01 | 0.384 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.135584e-01 | 0.383 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.135584e-01 | 0.383 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.136106e-01 | 0.383 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.195561e-01 | 0.377 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.195561e-01 | 0.377 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.195561e-01 | 0.377 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.254929e-01 | 0.371 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.276889e-01 | 0.369 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.313694e-01 | 0.365 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.371861e-01 | 0.359 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.415898e-01 | 0.355 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.450363e-01 | 0.352 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.484711e-01 | 0.348 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.486426e-01 | 0.348 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 4.492301e-01 | 0.348 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.518940e-01 | 0.345 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 4.542837e-01 | 0.343 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.542837e-01 | 0.343 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.598673e-01 | 0.337 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.653942e-01 | 0.332 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.653942e-01 | 0.332 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.653942e-01 | 0.332 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.654647e-01 | 0.332 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.654647e-01 | 0.332 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.676978e-01 | 0.330 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 4.708649e-01 | 0.327 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.755128e-01 | 0.323 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.782313e-01 | 0.320 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.816399e-01 | 0.317 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.816399e-01 | 0.317 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.869453e-01 | 0.313 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 4.869453e-01 | 0.313 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 4.973948e-01 | 0.303 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.973948e-01 | 0.303 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 4.973948e-01 | 0.303 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.999004e-01 | 0.301 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.025399e-01 | 0.299 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 5.072927e-01 | 0.295 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.076327e-01 | 0.294 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 5.076327e-01 | 0.294 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.113620e-01 | 0.291 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.126736e-01 | 0.290 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.126736e-01 | 0.290 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.126736e-01 | 0.290 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.177070e-01 | 0.286 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.208591e-01 | 0.283 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.226021e-01 | 0.282 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.226021e-01 | 0.282 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.240985e-01 | 0.281 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.244749e-01 | 0.280 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.302332e-01 | 0.276 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.323295e-01 | 0.274 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.371191e-01 | 0.270 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.411395e-01 | 0.267 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.418599e-01 | 0.266 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.455797e-01 | 0.263 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.455797e-01 | 0.263 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 5.557948e-01 | 0.255 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.558303e-01 | 0.255 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.664757e-01 | 0.247 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.676981e-01 | 0.246 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.693083e-01 | 0.245 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.693083e-01 | 0.245 | 1 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.693083e-01 | 0.245 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.693083e-01 | 0.245 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.737213e-01 | 0.241 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 5.866926e-01 | 0.232 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.866926e-01 | 0.232 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 5.866926e-01 | 0.232 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.951215e-01 | 0.225 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.960466e-01 | 0.225 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.992716e-01 | 0.222 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.034350e-01 | 0.219 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.061780e-01 | 0.217 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.074454e-01 | 0.216 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.143214e-01 | 0.212 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.232991e-01 | 0.205 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.232991e-01 | 0.205 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.309857e-01 | 0.200 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.422241e-01 | 0.192 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.458942e-01 | 0.190 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.495268e-01 | 0.187 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.602039e-01 | 0.180 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.636906e-01 | 0.178 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.636906e-01 | 0.178 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.671417e-01 | 0.176 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.705576e-01 | 0.174 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.739387e-01 | 0.171 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.739387e-01 | 0.171 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.748781e-01 | 0.171 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.805977e-01 | 0.167 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.838763e-01 | 0.165 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.856232e-01 | 0.164 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.903336e-01 | 0.161 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.935129e-01 | 0.159 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.935129e-01 | 0.159 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 6.997572e-01 | 0.155 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.021627e-01 | 0.154 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.028574e-01 | 0.153 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.059089e-01 | 0.151 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.089292e-01 | 0.149 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.089292e-01 | 0.149 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 7.148777e-01 | 0.146 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.207053e-01 | 0.142 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.264146e-01 | 0.139 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.292255e-01 | 0.137 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.320078e-01 | 0.135 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.347616e-01 | 0.134 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.355736e-01 | 0.133 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.374873e-01 | 0.132 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.374873e-01 | 0.132 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.401852e-01 | 0.131 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.428555e-01 | 0.129 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.481145e-01 | 0.126 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 7.558033e-01 | 0.122 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.639643e-01 | 0.117 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 7.797866e-01 | 0.108 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.820522e-01 | 0.107 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 8.042967e-01 | 0.095 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.074973e-01 | 0.093 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.094794e-01 | 0.092 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.190896e-01 | 0.087 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.282177e-01 | 0.082 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.282177e-01 | 0.082 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.317395e-01 | 0.080 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.346628e-01 | 0.078 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.351895e-01 | 0.078 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.351895e-01 | 0.078 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.368880e-01 | 0.077 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.390742e-01 | 0.076 | 0 | 0 |
| Translation | R-HSA-72766 | 8.424104e-01 | 0.074 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.467199e-01 | 0.072 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.568785e-01 | 0.067 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.853564e-01 | 0.053 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 8.877124e-01 | 0.052 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 8.987899e-01 | 0.046 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.235654e-01 | 0.035 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.289370e-01 | 0.032 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.311226e-01 | 0.031 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.455911e-01 | 0.024 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.573540e-01 | 0.019 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.612092e-01 | 0.017 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.615980e-01 | 0.017 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.713480e-01 | 0.013 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.716465e-01 | 0.012 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.784954e-01 | 0.009 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.805588e-01 | 0.009 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.816995e-01 | 0.008 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.965537e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.981886e-01 | 0.001 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999855e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999985e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999995e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 1 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.110223e-16 | 15.955 | 1 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.885781e-15 | 14.411 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.187939e-14 | 13.925 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.187939e-14 | 13.925 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.364775e-14 | 13.626 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.331468e-14 | 13.632 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.331468e-14 | 13.632 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.751755e-14 | 13.323 | 1 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.161738e-14 | 13.210 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.326673e-14 | 13.080 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.486589e-13 | 12.828 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.486589e-13 | 12.828 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.620926e-13 | 12.790 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.990630e-13 | 12.701 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.580158e-13 | 12.588 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.365086e-13 | 12.473 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.365086e-13 | 12.473 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.514966e-13 | 12.454 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.363176e-13 | 12.360 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.870548e-13 | 12.312 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.361889e-13 | 12.133 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.204237e-13 | 12.142 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.361889e-13 | 12.133 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.204237e-13 | 12.142 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.181544e-13 | 12.037 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.181544e-13 | 12.037 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.131428e-12 | 11.946 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.335043e-12 | 11.875 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.468381e-12 | 11.833 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.468381e-12 | 11.833 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.592060e-12 | 11.798 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.843414e-12 | 11.734 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.814970e-12 | 11.551 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.866041e-12 | 11.543 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.866041e-12 | 11.543 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.814970e-12 | 11.551 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.020784e-12 | 11.396 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.970824e-12 | 11.401 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.020784e-12 | 11.396 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.382916e-12 | 11.269 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.051049e-12 | 11.218 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.289125e-12 | 11.032 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.182920e-11 | 10.927 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.464517e-11 | 10.834 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.513545e-11 | 10.820 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.768108e-11 | 10.752 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.718037e-11 | 10.765 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.060685e-11 | 10.686 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.493328e-11 | 10.457 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.141942e-11 | 10.383 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.524614e-11 | 10.344 | 1 | 1 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.522127e-11 | 10.124 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.006326e-10 | 9.997 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.079821e-10 | 9.967 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.079821e-10 | 9.967 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.159097e-10 | 9.936 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.271321e-10 | 9.896 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.338261e-10 | 9.873 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.478446e-10 | 9.830 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.715651e-10 | 9.766 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.296109e-10 | 9.639 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.648366e-10 | 9.577 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.048798e-10 | 9.516 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.511220e-10 | 9.455 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.257556e-10 | 9.279 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.167372e-10 | 9.210 | 1 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.832913e-10 | 9.165 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.673909e-10 | 9.115 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.545436e-10 | 9.020 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.822849e-10 | 9.054 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.000214e-09 | 9.000 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.118599e-09 | 8.951 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.313667e-09 | 8.882 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.444295e-09 | 8.840 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.421730e-09 | 8.616 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.995218e-09 | 8.524 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.947192e-09 | 8.531 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.022886e-09 | 8.520 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.243399e-09 | 8.489 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.622220e-09 | 8.441 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.030775e-09 | 8.395 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.742139e-09 | 8.324 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.009705e-09 | 8.300 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.373972e-09 | 8.270 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.805245e-09 | 8.167 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.169009e-09 | 8.088 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.733173e-09 | 8.012 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.061263e-08 | 7.974 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.376193e-08 | 7.861 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.408437e-08 | 7.851 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.618485e-08 | 7.791 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.618485e-08 | 7.791 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.618485e-08 | 7.791 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.828214e-08 | 7.738 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.828214e-08 | 7.738 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.928025e-08 | 7.715 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.124079e-08 | 7.673 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.207080e-08 | 7.656 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.340742e-08 | 7.631 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.618409e-08 | 7.582 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.091039e-08 | 7.388 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.138609e-08 | 7.289 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.151538e-08 | 7.288 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.850141e-08 | 7.233 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.194668e-08 | 7.208 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.897743e-08 | 7.102 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.008255e-07 | 6.996 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.328817e-07 | 6.877 | 1 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.591335e-07 | 6.798 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.699319e-07 | 6.770 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.939948e-07 | 6.712 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.988341e-07 | 6.525 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.351934e-07 | 6.475 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.166129e-07 | 6.380 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.471601e-07 | 6.262 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.388911e-07 | 6.195 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.098214e-07 | 6.149 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.799453e-07 | 6.108 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.912420e-07 | 6.102 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.284486e-07 | 6.082 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.191866e-06 | 5.924 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.281309e-06 | 5.892 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.395935e-06 | 5.855 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.708311e-06 | 5.767 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.980705e-06 | 5.703 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.446334e-06 | 5.611 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.446334e-06 | 5.611 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.051437e-06 | 5.515 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.306425e-06 | 5.481 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.579242e-06 | 5.446 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.384626e-06 | 5.358 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.652623e-06 | 5.332 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.096057e-06 | 5.293 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.409554e-06 | 5.267 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.717637e-06 | 5.243 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.002352e-06 | 5.222 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.356174e-06 | 5.197 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.511287e-06 | 5.186 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 7.573878e-06 | 5.121 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.573878e-06 | 5.121 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.064521e-06 | 5.093 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.405842e-06 | 5.075 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.706815e-06 | 5.060 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.151472e-06 | 5.039 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.128576e-05 | 4.947 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.175012e-05 | 4.930 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.273430e-05 | 4.895 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.578397e-05 | 4.802 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.705175e-05 | 4.768 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.719314e-05 | 4.765 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.127930e-05 | 4.672 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.293808e-05 | 4.639 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.458600e-05 | 4.609 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.647619e-05 | 4.577 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.933134e-05 | 4.533 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.223398e-05 | 4.492 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.769461e-05 | 4.424 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.323479e-05 | 4.199 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.128216e-05 | 4.147 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.385977e-05 | 4.076 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.148890e-04 | 3.940 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.351079e-04 | 3.869 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.551699e-04 | 3.809 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.786234e-04 | 3.748 | 1 | 0 |
| DNA Repair | R-HSA-73894 | 1.823240e-04 | 3.739 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.929322e-04 | 3.715 | 1 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.596635e-04 | 3.444 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.370168e-04 | 3.270 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.705173e-04 | 3.244 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.806713e-04 | 3.236 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 6.024845e-04 | 3.220 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.449091e-04 | 3.191 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.644395e-04 | 3.178 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.717560e-04 | 3.173 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 9.462599e-04 | 3.024 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.462599e-04 | 3.024 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.117144e-04 | 3.040 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.037171e-04 | 3.044 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.633827e-04 | 3.117 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.601537e-04 | 3.119 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.652550e-04 | 3.015 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 1.023741e-03 | 2.990 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.030154e-03 | 2.987 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.068964e-03 | 2.971 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.204604e-03 | 2.919 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.368430e-03 | 2.864 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.408933e-03 | 2.851 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.452692e-03 | 2.838 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.453342e-03 | 2.838 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.488570e-03 | 2.827 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.544297e-03 | 2.811 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.648266e-03 | 2.783 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.921533e-03 | 2.716 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.049674e-03 | 2.688 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.354838e-03 | 2.628 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.569824e-03 | 2.590 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.647131e-03 | 2.577 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.824815e-03 | 2.549 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.824815e-03 | 2.549 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.995834e-03 | 2.523 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.138718e-03 | 2.503 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.180627e-03 | 2.497 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.341838e-03 | 2.476 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.487050e-03 | 2.458 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.487050e-03 | 2.458 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.845938e-03 | 2.415 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.982783e-03 | 2.400 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.982783e-03 | 2.400 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.982783e-03 | 2.400 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.982783e-03 | 2.400 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.982783e-03 | 2.400 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.247643e-03 | 2.372 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.622775e-03 | 2.335 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.343217e-03 | 2.198 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.533498e-03 | 2.257 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.533498e-03 | 2.257 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.533498e-03 | 2.257 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.041173e-03 | 2.297 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.343217e-03 | 2.198 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.177584e-03 | 2.286 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.326382e-03 | 2.274 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.343217e-03 | 2.198 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.461985e-03 | 2.263 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.192163e-03 | 2.285 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.668789e-03 | 2.176 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.179359e-03 | 2.144 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.179359e-03 | 2.144 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.179359e-03 | 2.144 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.573414e-03 | 2.121 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.616677e-03 | 2.118 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.616677e-03 | 2.118 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.231918e-03 | 2.084 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.995316e-03 | 2.046 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.995316e-03 | 2.046 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.995316e-03 | 2.046 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 9.086120e-03 | 2.042 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.327370e-03 | 2.030 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.739998e-03 | 2.011 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.047653e-02 | 1.980 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.047653e-02 | 1.980 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.047653e-02 | 1.980 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.050632e-02 | 1.979 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.121487e-02 | 1.950 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.142449e-02 | 1.942 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.373652e-02 | 1.862 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.435327e-02 | 1.843 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.459202e-02 | 1.836 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.519504e-02 | 1.818 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.737673e-02 | 1.760 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.737673e-02 | 1.760 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.737673e-02 | 1.760 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.737673e-02 | 1.760 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.741710e-02 | 1.759 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.741710e-02 | 1.759 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.933340e-02 | 1.714 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.933340e-02 | 1.714 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.945802e-02 | 1.711 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.945802e-02 | 1.711 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.137797e-02 | 1.670 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.162551e-02 | 1.665 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.184536e-02 | 1.661 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.320194e-02 | 1.634 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.350815e-02 | 1.629 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.369527e-02 | 1.625 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.471967e-02 | 1.607 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.572169e-02 | 1.590 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.572169e-02 | 1.590 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.572169e-02 | 1.590 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.650984e-02 | 1.577 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.691609e-02 | 1.570 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.711701e-02 | 1.567 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.801637e-02 | 1.553 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.801637e-02 | 1.553 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.801637e-02 | 1.553 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.460131e-02 | 1.461 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.460131e-02 | 1.461 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.039003e-02 | 1.517 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.796366e-02 | 1.421 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.796366e-02 | 1.421 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.336949e-02 | 1.363 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.336949e-02 | 1.363 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.728275e-02 | 1.428 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.032899e-02 | 1.394 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.460131e-02 | 1.461 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.460131e-02 | 1.461 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.284052e-02 | 1.484 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.336949e-02 | 1.363 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.413445e-02 | 1.467 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.580582e-02 | 1.446 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.284052e-02 | 1.484 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.612013e-02 | 1.442 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.032294e-02 | 1.518 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.211235e-02 | 1.493 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.796366e-02 | 1.421 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.147053e-02 | 1.382 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.586882e-02 | 1.445 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.796366e-02 | 1.421 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.063224e-02 | 1.391 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.063224e-02 | 1.391 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.349735e-02 | 1.362 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.396170e-02 | 1.357 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.512692e-02 | 1.346 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.586834e-02 | 1.338 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.586834e-02 | 1.338 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.586834e-02 | 1.338 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.586834e-02 | 1.338 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.586834e-02 | 1.338 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.586834e-02 | 1.338 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.586834e-02 | 1.338 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.586834e-02 | 1.338 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.586834e-02 | 1.338 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.586834e-02 | 1.338 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.586834e-02 | 1.338 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.586834e-02 | 1.338 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.586834e-02 | 1.338 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.586834e-02 | 1.338 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.586834e-02 | 1.338 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.586834e-02 | 1.338 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.586834e-02 | 1.338 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.617348e-02 | 1.336 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.678650e-02 | 1.330 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.883867e-02 | 1.311 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.904228e-02 | 1.309 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.194341e-02 | 1.284 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.400256e-02 | 1.268 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.400256e-02 | 1.268 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.496688e-02 | 1.260 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 5.561240e-02 | 1.255 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.700456e-02 | 1.244 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.700456e-02 | 1.244 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.801902e-02 | 1.236 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.429411e-02 | 1.192 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.751361e-02 | 1.171 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.751361e-02 | 1.171 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.751361e-02 | 1.171 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.801148e-02 | 1.167 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.801148e-02 | 1.167 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.801148e-02 | 1.167 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 6.801148e-02 | 1.167 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.801148e-02 | 1.167 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.801148e-02 | 1.167 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.815224e-02 | 1.167 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.815224e-02 | 1.167 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.078550e-02 | 1.150 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.078550e-02 | 1.150 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.305263e-02 | 1.136 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.356578e-02 | 1.133 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.410813e-02 | 1.130 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.410813e-02 | 1.130 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.513568e-02 | 1.124 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.747989e-02 | 1.111 | 1 | 1 |
| IRS activation | R-HSA-74713 | 7.889060e-02 | 1.103 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 7.889060e-02 | 1.103 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 7.889060e-02 | 1.103 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.889060e-02 | 1.103 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.889060e-02 | 1.103 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 7.889060e-02 | 1.103 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.908753e-02 | 1.102 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 8.964339e-02 | 1.047 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.964339e-02 | 1.047 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 8.964339e-02 | 1.047 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 8.964339e-02 | 1.047 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.964339e-02 | 1.047 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.002713e-01 | 0.999 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.002713e-01 | 0.999 | 1 | 1 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.002713e-01 | 0.999 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.107758e-01 | 0.956 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.107758e-01 | 0.956 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.211583e-01 | 0.917 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.211583e-01 | 0.917 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.211583e-01 | 0.917 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.211583e-01 | 0.917 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.211583e-01 | 0.917 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.314202e-01 | 0.881 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.614962e-01 | 0.792 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.089920e-02 | 1.092 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.375942e-01 | 0.861 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.415629e-01 | 0.849 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.515878e-01 | 0.819 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.211583e-01 | 0.917 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.614962e-01 | 0.792 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.251020e-01 | 0.903 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.251020e-01 | 0.903 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.964339e-02 | 1.047 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.865549e-02 | 1.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.436449e-02 | 1.074 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.212253e-01 | 0.916 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.964339e-02 | 1.047 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.107758e-01 | 0.956 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.415629e-01 | 0.849 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.515878e-01 | 0.819 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.244630e-01 | 0.905 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.225814e-01 | 0.912 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.314202e-01 | 0.881 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.787425e-02 | 1.056 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 1.515878e-01 | 0.819 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.614962e-01 | 0.792 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.286205e-01 | 0.891 | 1 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.449041e-01 | 0.839 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.449041e-01 | 0.839 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 1.107758e-01 | 0.956 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.314202e-01 | 0.881 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.415629e-01 | 0.849 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.327147e-01 | 0.877 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.142698e-02 | 1.039 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.017870e-01 | 0.992 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.002713e-01 | 0.999 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.314202e-01 | 0.881 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.314202e-01 | 0.881 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.415629e-01 | 0.849 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.614962e-01 | 0.792 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.496131e-01 | 0.825 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.539405e-01 | 0.813 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.369042e-01 | 0.864 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.069121e-01 | 0.971 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.787425e-02 | 1.056 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.964339e-02 | 1.047 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 1.002713e-01 | 0.999 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.002713e-01 | 0.999 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.314202e-01 | 0.881 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.251020e-01 | 0.903 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.449041e-01 | 0.839 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 1.244630e-01 | 0.905 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.258558e-02 | 1.033 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.329426e-01 | 0.876 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.865549e-02 | 1.006 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.583590e-01 | 0.800 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.173794e-01 | 0.930 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.391286e-01 | 0.857 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.449041e-01 | 0.839 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.044898e-01 | 0.981 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.395053e-02 | 1.076 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.318669e-02 | 1.031 | 1 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.314202e-01 | 0.881 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.415629e-01 | 0.849 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.020897e-01 | 0.991 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.557362e-01 | 0.808 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.436449e-02 | 1.074 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.211583e-01 | 0.917 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.368622e-01 | 0.864 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.142698e-02 | 1.039 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.212253e-01 | 0.916 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.570790e-01 | 0.804 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.408917e-01 | 0.851 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.212253e-01 | 0.916 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.410619e-01 | 0.851 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.570790e-01 | 0.804 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.712895e-01 | 0.766 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 1.712895e-01 | 0.766 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 1.712895e-01 | 0.766 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.712895e-01 | 0.766 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.712895e-01 | 0.766 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.712895e-01 | 0.766 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.712895e-01 | 0.766 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.712895e-01 | 0.766 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 1.712895e-01 | 0.766 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.712895e-01 | 0.766 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.735947e-01 | 0.760 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.735947e-01 | 0.760 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.777674e-01 | 0.750 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.809691e-01 | 0.742 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.809691e-01 | 0.742 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.809691e-01 | 0.742 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.809691e-01 | 0.742 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.822615e-01 | 0.739 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.833357e-01 | 0.737 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.853515e-01 | 0.732 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 1.882879e-01 | 0.725 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.905361e-01 | 0.720 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.905361e-01 | 0.720 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.905361e-01 | 0.720 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.905361e-01 | 0.720 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.905361e-01 | 0.720 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.941966e-01 | 0.712 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.988460e-01 | 0.701 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.988460e-01 | 0.701 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.999920e-01 | 0.699 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.999920e-01 | 0.699 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.999920e-01 | 0.699 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.999920e-01 | 0.699 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.999920e-01 | 0.699 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.999920e-01 | 0.699 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.999920e-01 | 0.699 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.999920e-01 | 0.699 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.001511e-01 | 0.699 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.030986e-01 | 0.692 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.030986e-01 | 0.692 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.031447e-01 | 0.692 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.093380e-01 | 0.679 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 2.093380e-01 | 0.679 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 2.093380e-01 | 0.679 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.093380e-01 | 0.679 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.093380e-01 | 0.679 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.093380e-01 | 0.679 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.093380e-01 | 0.679 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.093380e-01 | 0.679 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 2.185754e-01 | 0.660 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 2.185754e-01 | 0.660 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.185754e-01 | 0.660 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.185754e-01 | 0.660 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.185754e-01 | 0.660 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.185754e-01 | 0.660 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.185754e-01 | 0.660 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.245002e-01 | 0.649 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.245002e-01 | 0.649 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.266924e-01 | 0.645 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.274465e-01 | 0.643 | 1 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.277055e-01 | 0.643 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 2.277055e-01 | 0.643 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 2.277055e-01 | 0.643 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.277055e-01 | 0.643 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.367015e-01 | 0.626 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.367294e-01 | 0.626 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.367294e-01 | 0.626 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.367294e-01 | 0.626 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.367294e-01 | 0.626 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.367294e-01 | 0.626 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.367294e-01 | 0.626 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.374243e-01 | 0.624 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.374243e-01 | 0.624 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.374243e-01 | 0.624 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 2.374243e-01 | 0.624 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 2.417418e-01 | 0.617 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.456484e-01 | 0.610 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.456484e-01 | 0.610 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 2.456484e-01 | 0.610 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.456484e-01 | 0.610 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.456484e-01 | 0.610 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.456484e-01 | 0.610 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.456484e-01 | 0.610 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.522670e-01 | 0.598 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.544638e-01 | 0.594 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.544638e-01 | 0.594 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.544638e-01 | 0.594 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.544638e-01 | 0.594 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.544638e-01 | 0.594 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.631767e-01 | 0.580 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.631767e-01 | 0.580 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.676991e-01 | 0.572 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.717883e-01 | 0.566 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.717883e-01 | 0.566 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.717883e-01 | 0.566 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.717883e-01 | 0.566 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 2.717883e-01 | 0.566 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.720282e-01 | 0.565 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.763564e-01 | 0.559 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.799198e-01 | 0.553 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.799198e-01 | 0.553 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.802997e-01 | 0.552 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.802997e-01 | 0.552 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.802997e-01 | 0.552 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.802997e-01 | 0.552 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.802997e-01 | 0.552 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.806283e-01 | 0.552 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.806283e-01 | 0.552 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.806283e-01 | 0.552 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 2.806834e-01 | 0.552 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.806834e-01 | 0.552 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.838001e-01 | 0.547 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.887122e-01 | 0.540 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.887122e-01 | 0.540 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.887122e-01 | 0.540 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.887122e-01 | 0.540 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.887122e-01 | 0.540 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.887122e-01 | 0.540 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.970269e-01 | 0.527 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.970269e-01 | 0.527 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.970269e-01 | 0.527 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.970269e-01 | 0.527 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.970269e-01 | 0.527 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.970269e-01 | 0.527 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.979666e-01 | 0.526 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.022787e-01 | 0.520 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.052449e-01 | 0.515 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.052449e-01 | 0.515 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.052449e-01 | 0.515 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.052449e-01 | 0.515 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.052449e-01 | 0.515 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.052449e-01 | 0.515 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.108890e-01 | 0.507 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.133674e-01 | 0.504 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.133674e-01 | 0.504 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.156503e-01 | 0.501 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.213953e-01 | 0.493 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.213953e-01 | 0.493 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 3.213953e-01 | 0.493 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.213953e-01 | 0.493 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.213953e-01 | 0.493 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.214106e-01 | 0.493 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.293299e-01 | 0.482 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.293299e-01 | 0.482 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.293299e-01 | 0.482 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.293299e-01 | 0.482 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.293299e-01 | 0.482 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.293299e-01 | 0.482 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.365748e-01 | 0.473 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.365748e-01 | 0.473 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.371722e-01 | 0.472 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 3.371722e-01 | 0.472 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.371722e-01 | 0.472 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.371722e-01 | 0.472 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 3.408302e-01 | 0.467 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.408302e-01 | 0.467 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.432146e-01 | 0.464 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.449233e-01 | 0.462 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.449233e-01 | 0.462 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.449233e-01 | 0.462 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.449233e-01 | 0.462 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.449233e-01 | 0.462 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 3.450771e-01 | 0.462 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.525842e-01 | 0.453 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.525842e-01 | 0.453 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.525842e-01 | 0.453 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.601560e-01 | 0.444 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.619731e-01 | 0.441 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.661724e-01 | 0.436 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.676397e-01 | 0.435 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.676397e-01 | 0.435 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.676397e-01 | 0.435 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.676397e-01 | 0.435 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.750364e-01 | 0.426 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.750364e-01 | 0.426 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.823469e-01 | 0.418 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 3.823469e-01 | 0.418 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.823469e-01 | 0.418 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.823469e-01 | 0.418 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.823469e-01 | 0.418 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 3.823469e-01 | 0.418 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.823469e-01 | 0.418 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 3.823469e-01 | 0.418 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.895724e-01 | 0.409 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.895724e-01 | 0.409 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 3.895724e-01 | 0.409 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 3.967138e-01 | 0.402 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.967138e-01 | 0.402 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.967138e-01 | 0.402 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.967138e-01 | 0.402 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.982890e-01 | 0.400 | 1 | 1 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.993607e-01 | 0.399 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.037721e-01 | 0.394 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.037721e-01 | 0.394 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.037721e-01 | 0.394 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.075342e-01 | 0.390 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.075342e-01 | 0.390 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.107483e-01 | 0.386 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.107483e-01 | 0.386 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.108211e-01 | 0.386 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.176432e-01 | 0.379 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.176432e-01 | 0.379 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.176432e-01 | 0.379 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.176432e-01 | 0.379 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 4.178835e-01 | 0.379 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.196931e-01 | 0.377 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.196931e-01 | 0.377 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.244579e-01 | 0.372 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.244579e-01 | 0.372 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.244579e-01 | 0.372 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.244579e-01 | 0.372 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.244579e-01 | 0.372 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.311933e-01 | 0.365 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.311933e-01 | 0.365 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.311933e-01 | 0.365 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 4.378503e-01 | 0.359 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.378503e-01 | 0.359 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.479025e-01 | 0.349 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.553846e-01 | 0.342 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.573597e-01 | 0.340 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.573597e-01 | 0.340 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.573597e-01 | 0.340 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.573597e-01 | 0.340 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.637120e-01 | 0.334 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 4.637120e-01 | 0.334 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.637120e-01 | 0.334 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.637120e-01 | 0.334 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.637120e-01 | 0.334 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.699903e-01 | 0.328 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.699903e-01 | 0.328 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.699903e-01 | 0.328 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.699903e-01 | 0.328 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.708427e-01 | 0.327 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.708427e-01 | 0.327 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.761955e-01 | 0.322 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.784734e-01 | 0.320 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.822637e-01 | 0.317 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.823285e-01 | 0.317 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.823285e-01 | 0.317 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 4.823285e-01 | 0.317 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.823285e-01 | 0.317 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.935326e-01 | 0.307 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.943809e-01 | 0.306 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.943809e-01 | 0.306 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.943809e-01 | 0.306 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.003020e-01 | 0.301 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.061541e-01 | 0.296 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.061541e-01 | 0.296 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.061541e-01 | 0.296 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.061541e-01 | 0.296 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.066873e-01 | 0.295 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.119381e-01 | 0.291 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.119381e-01 | 0.291 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.176547e-01 | 0.286 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.233046e-01 | 0.281 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.233046e-01 | 0.281 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.233046e-01 | 0.281 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.288888e-01 | 0.277 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.288888e-01 | 0.277 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 5.288888e-01 | 0.277 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.288888e-01 | 0.277 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 5.300127e-01 | 0.276 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.344078e-01 | 0.272 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.398626e-01 | 0.268 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 5.452537e-01 | 0.263 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.452537e-01 | 0.263 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.452537e-01 | 0.263 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.452537e-01 | 0.263 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.474992e-01 | 0.262 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 5.505821e-01 | 0.259 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.558483e-01 | 0.255 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.558483e-01 | 0.255 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.610532e-01 | 0.251 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.610532e-01 | 0.251 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.661973e-01 | 0.247 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.712815e-01 | 0.243 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.712815e-01 | 0.243 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.712815e-01 | 0.243 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.712815e-01 | 0.243 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.763064e-01 | 0.239 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.779074e-01 | 0.238 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.779074e-01 | 0.238 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.811930e-01 | 0.236 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 5.861812e-01 | 0.232 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.861812e-01 | 0.232 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.877080e-01 | 0.231 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 5.910324e-01 | 0.228 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.910324e-01 | 0.228 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.973401e-01 | 0.224 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.005133e-01 | 0.221 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.005657e-01 | 0.221 | 1 | 1 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.005657e-01 | 0.221 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.005657e-01 | 0.221 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.036677e-01 | 0.219 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 6.052491e-01 | 0.218 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 6.052491e-01 | 0.218 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.052491e-01 | 0.218 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.098779e-01 | 0.215 | 1 | 1 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.098779e-01 | 0.215 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.098779e-01 | 0.215 | 0 | 0 |
| Translation | R-HSA-72766 | 6.104580e-01 | 0.214 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.130186e-01 | 0.213 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.144527e-01 | 0.212 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.144527e-01 | 0.212 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.144527e-01 | 0.212 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.161587e-01 | 0.210 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.189742e-01 | 0.208 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.191590e-01 | 0.208 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.278594e-01 | 0.202 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 6.408023e-01 | 0.193 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.450163e-01 | 0.190 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.450163e-01 | 0.190 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.450163e-01 | 0.190 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.532974e-01 | 0.185 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.544376e-01 | 0.184 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.600588e-01 | 0.180 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.600588e-01 | 0.180 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.613862e-01 | 0.180 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.692873e-01 | 0.174 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.692873e-01 | 0.174 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.692873e-01 | 0.174 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 6.737929e-01 | 0.171 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.770051e-01 | 0.169 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.807965e-01 | 0.167 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.845436e-01 | 0.165 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.882470e-01 | 0.162 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 6.896789e-01 | 0.161 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.919071e-01 | 0.160 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.955244e-01 | 0.158 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.990996e-01 | 0.155 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.990996e-01 | 0.155 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.095763e-01 | 0.149 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.129873e-01 | 0.147 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.129873e-01 | 0.147 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.129873e-01 | 0.147 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.163584e-01 | 0.145 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.163584e-01 | 0.145 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.229830e-01 | 0.141 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.229830e-01 | 0.141 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.229830e-01 | 0.141 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 7.262373e-01 | 0.139 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.262373e-01 | 0.139 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.294536e-01 | 0.137 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.326323e-01 | 0.135 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.326323e-01 | 0.135 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.335602e-01 | 0.135 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.357739e-01 | 0.133 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.357739e-01 | 0.133 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.388787e-01 | 0.131 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.419472e-01 | 0.130 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.419472e-01 | 0.130 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.419472e-01 | 0.130 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 7.447800e-01 | 0.128 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.479771e-01 | 0.126 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.509393e-01 | 0.124 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.538668e-01 | 0.123 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.538668e-01 | 0.123 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.567601e-01 | 0.121 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.567601e-01 | 0.121 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.567601e-01 | 0.121 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.596196e-01 | 0.119 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.596196e-01 | 0.119 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 7.624457e-01 | 0.118 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.660141e-01 | 0.116 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.679990e-01 | 0.115 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.679990e-01 | 0.115 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.680513e-01 | 0.115 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.707270e-01 | 0.113 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.787211e-01 | 0.109 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.813237e-01 | 0.107 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.864379e-01 | 0.104 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.914331e-01 | 0.102 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.914331e-01 | 0.102 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.914331e-01 | 0.102 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.987089e-01 | 0.098 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.987089e-01 | 0.098 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.034185e-01 | 0.095 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 8.039316e-01 | 0.095 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.253724e-01 | 0.083 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.305815e-01 | 0.081 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 8.373554e-01 | 0.077 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.392714e-01 | 0.076 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.392714e-01 | 0.076 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.533599e-01 | 0.069 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.589223e-01 | 0.066 | 1 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.654591e-01 | 0.063 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.654591e-01 | 0.063 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.654591e-01 | 0.063 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.747037e-01 | 0.058 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.761818e-01 | 0.057 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.833161e-01 | 0.054 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.833161e-01 | 0.054 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.938901e-01 | 0.049 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.126125e-01 | 0.040 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.143245e-01 | 0.039 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.183045e-01 | 0.037 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.248320e-01 | 0.034 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.274681e-01 | 0.033 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.274681e-01 | 0.033 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.356087e-01 | 0.029 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.400498e-01 | 0.027 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.461465e-01 | 0.024 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.474153e-01 | 0.023 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.653700e-01 | 0.015 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.674316e-01 | 0.014 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.690392e-01 | 0.014 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.707061e-01 | 0.013 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.760976e-01 | 0.011 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.796368e-01 | 0.009 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.831138e-01 | 0.007 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.917885e-01 | 0.004 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.938505e-01 | 0.003 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.938505e-01 | 0.003 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.958177e-01 | 0.002 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.958972e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.982254e-01 | 0.001 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.984894e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.998277e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999278e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999947e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999982e-01 | 0.000 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.000000e+00 | 0.000 | 1 | 1 |